Develops a photoaffinity labeling platform to identify novel protein targets of quinazolinone-based bioactive molecules. Thymosin β4 was identified as effectively enriched by the QDAU5 probe, suggesting Tβ4 may be a binding target of quinazolinone compounds. This unexpected finding suggests an additional mechanism through which quinazolinone-class drugs may exert biological effects—and identifies Tβ4 as a potentially druggable target for small-molecule interaction, with implications for TB4-modulating pharmacology.
Li, Yanchen; Liu, Tingting; Zhang, Kun; Wang, Jin; Zhang, Junyu; Zhang, Jie